MiMedx | Innovations in Regenerative Biomaterials

MiMedx® is a leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. “Innovations in Regenerative Medicine” is the framework behind our mission to provide physicians with products and tissues to help the body heal itself.
Today we are a leader in advanced wound care, spine and sports medicine with significant scientific, clinical, operational and commercialization expertise. We intend to leverage these capabilities to remain at the forefront of innovation in regenerative medicine and biopharmaceuticals.

Since our founding, research and development has been the cornerstone of our organization. As a result, we have grown to be a leader in placental based products with over 40 scientific and clinical publications contained in our Compendium, seven completed and published Randomized Controlled Trials (RCTs), and 30 ongoing clinical studies. MiMedx has over 45 placental tissue issued and allowed patents on our products and technologies, with over 90 pending applications.

MiMedx amniotic membrane allografts, processed using the Company’s proprietary PURION^® process, utilize terminal sterilization as an essential part of the process. Terminal sterilization provides a greater safety factor than the typical drug or tissue products only processed aseptically.
The proprietary PURION processing technology provides the MiMedx amniotic membrane allografts with their unique capabilities to retain growth factors, provide ease of use by the physician, and offer the capacity to be stored at ambient conditions with a five year shelf life. Read more about what MiMedx does to protect safety

Explore our recently published multicenter RCTs

1,500,000 ALLOGRAFTS DISTRIBUTED

OVER 40 SCIENTIFIC AND CLINICAL PUBLICATIONS

THE PURION PROCESS

The MiMedx Difference

Our Products

Investors

Our Company

Our Products

Our Science

Resources

Contact Us